News

EUnetHTA 21 is pleased to announce the publication of the EUnetHTA 21 deliverable ”JCA without HTD submission”. We thank everyone involved for their work on

The European Health and Digital Executive Agency (HADEA) signed the Service Contract for the Provision of Joint Health Technology Assessment (HTA) Work Supporting the Continuation

In 2022 the EUnetHTA 21 Consortium worked together to produce a number of guidelineswhich outline the methods that are used to undertake Joint Clinical Assessments

EUnetHTA 21 is pleased to announce the publication of the EUnetHTA 21 – EMA work plan. EMA and EUnetHTA 21 work closely together, to prepare for

The EUnetHTA 21 is pleased to announce the publication of their second Joint Clinical Assessment. One of the objective of the JCA production was to

The Parallel EMA/EUnetHTA 21 Joint Scientific Consultations (JSCs) under the EUnetHTA 21 service contract will have to be completed by September 2023 and all available

EUnetHTA 21 announces that the public consultation for the deliverables ‘’D6.2.1 Briefing Document Template’’ and ‘’D6.4.1 External Guidance with EMA’’ will be open for public

The EUnetHTA 21 is pleased to announce the publication of the draft version of the D5.4 deliverable on medicinal JCA timelines. Please note, that this

The EUnetHTA 21 is pleased to announce the publication of their first Joint Clinical Assessment. One of the objective of the JCA production was to

The European Health and Digital Executive Agency (HADEA) signed the Service Contract for the Provision of Joint Health Technology Assessment (HTA) Work Supporting the Continuation